Dr. Brian Barnett shows the inside of the dosing room at Cleveland Clinic Lutheran where participants in a study looking at ...

Psychedelic drugs are seeing a surge of interest from mainstream medicine, and initial results suggest that ...

Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.

Taking LSD or magic mushrooms may not be the cause of schizotypal traits. Psychedelic drugs are experiencing a resurgence of ...

Mind Medicine is developing MM120, a fast-acting, single-dose treatment for anxiety and depressive disorders. Read more on ...

University of Michigan researchers have found that certain psychedelic compounds improve the brain’s ability to adapt and ...

Since 2019, these higher levels of psilocybin use reflected an increase of 188% among adults 30 and older and 44% among 18- ...

Psilocybin has been studied as a possible treatment for post-traumatic stress disorder (PTSD), depression and substance use ...

Use of psilocybin, the hallucinogenic chemical found in what is known as 'magic mushrooms,' has increased significantly nationwide since 2019, according to a new study.

Learn how psychedelics can enhance adaptability in the brain, improving learning and memory for conditions like PTSD.

A single psychedelic dose unexpectedly boosted long-lasting cognitive flexibility in mice, hinting at mental health benefits.